PF-543,
PF-543,
1415562-82-1,
Sphingosine Kinase 1 Inhibitor II,
PF 543,
CHEMBL3134157,
PF543,
{(2R)-1-[4-({3-METHYL-5-[(PHENYLSULFONYL)METHYL]PHENOXY}METHYL)BENZYL]PYRROLIDIN-2-YL}METHANOL,
C27H31NO4S,
GTPL6623,
SCHEMBL17786131,
DTXSID90735359,
CHEBI:131144,
BCP07072,
BDBM50041978,
ZINC94568743,
AKOS030526503,
CS-0869,
SB19553,
compound 22a [PMID: 22397330],
NCGC00346972-04,
2-Pyrrolidinemethanol, 1-[[4-[[3-methyl-5-[(phenylsulfonyl)methyl]phenoxy]methyl]phenyl]methyl]-, (2R)-,
HY-15425,
SC-94571,
S7177,
SW218168-2,
X5812,
S-7832,
BRD-K79877282-001-01-9,
(2R)-1-[[4-[[3-Methyl-5-[(phenylsulfonyl)methyl]phenoxy]methyl]phenyl]methyl]-2-pyrrolidinemethanol,
[(2R)-1-[(4-{3-[(benzenesulfonyl)methyl]-5-methylphenoxymethyl}phenyl)methyl]pyrrolidin-2-yl]methanol,
[(2R)-1-{[4-({3-[(Benzenesulfonyl)methyl]-5-methylphenoxy}methyl)phenyl]methyl}pyrrolidin-2-yl]methanol,
D08SND,
ACN-032408,
A3717,
GYR,
PF-543(2R)-1-[[4-[[3-Methyl-5-[(phenylsulfonyl)Methyl]phenoxy]Methyl]phenyl]Methyl]-2-pyrrolidineMethanol,